Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.0K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.0K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.2K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
1.2K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.3K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.3K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

85
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
85

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Benchmarking community drug response prediction models: datasets, models, tools, and metrics for cross-dataset generalization analysis.

Briefings in bioinformatics·2026
Same author

Resting-state global brain activity induces bias in fMRI motion estimates.

Imaging neuroscience (Cambridge, Mass.)·2025
Same author

Predictive Modeling of Anticancer Drug Sensitivity Using REFINED CNN.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Low-dose dietary vorinostat increases brain histone acetylation levels and reduces oxidative stress in an Alzheimer's disease mouse model.

Journal of Alzheimer's disease : JAD·2025
Same author

Hyperspectral imaging to characterize the vegetative tissue biochemical changes in response to water deficit conditions in sorghum (<i>Sorghum bicolor</i>).

Frontiers in plant science·2025
Same author

Cross study transcriptomic investigation of Alzheimer's brain tissue discoveries and limitations.

Scientific reports·2025

関連する実験動画

Updated: Sep 9, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

AdapTor: 定量的構造-活動関係モデリングのための適応的トポロジック回帰

Yixiang Mao1, Souparno Ghosh2, Ranadip Pal3

  • 1Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, TX, 79409, USA.

Journal of cheminformatics
|August 28, 2025
PubMed
まとめ
この要約は機械生成です。

Adaptive Topological Regression (AdapToR) は,定量構造-活性関係 (QSAR) モデルを強化することで,薬剤設計を改善する. この新しい方法は 薬剤反応の予測を良くし 解釈しやすさを高め 計算コストを削減します

キーワード:
癌薬に対する反応の予測薬物の発見解釈可能な機械学習QSARモデリングトポロジック回帰

さらに関連する動画

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K
Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.5K

関連する実験動画

Last Updated: Sep 9, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

14.1K
Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.5K

科学分野:

  • コンピュータ化学
  • 化学情報学
  • 薬の発見と開発

背景:

  • 定量的な構造-活性関係 (QSAR) モデリングは,薬物の設計に不可欠です.
  • トポロジカル・リグレッション (TR) は効率と解釈性を提供しているが,アンカー選択と再構築には限界がある.
  • ディープラーニングを含む既存のQSARモデルは,予測力と解釈性のバランスをとる上で課題に直面しています.

研究 の 目的:

  • 改良されたQSARモデルであるアダプティブ・トポロジック・リグレッション (AdapToR) を導入する.
  • 適応性アンカー選択と最適化ベースの再構築を実装することによって,標準TRの限界を克服する.
  • 薬剤反応予測モデルの正確性,解釈性,計算効率を改善する.

主な方法:

  • AdapToRを開発し,新しい適応アンカー選択戦略を開発しました.
  • レスポンス再構築のための最適化ベースのアプローチを実装した.
  • NCI60 GI50データセットで評価されたAdapToRは,60のがん細胞系で50,000以上の薬剤反応を含んでいます.
  • AdapToRとTransformer CNN,グラフトランスフォーマー,TR,その他のベースラインQSARモデルを比較した.

主要な成果:

  • AdapToRは,既存のQSARモデルと比較して,薬剤反応を予測する上で優れたパフォーマンスを示しました.
  • 提案された方法は,ディープラーニングベースのモデルよりも大幅に低い計算コストを達成しました.
  • AdapToRは,複雑なディープラーニングアーキテクチャと比較して,QSARモデリングでより高い解釈性を提供します.

結論:

  • AdapToRは,薬剤反応の予測のためのQSARモデルの重要な進歩を表しています.
  • このモデルは予測精度,解釈可能性,計算効率を効果的にバランスします.
  • AdapToRは 薬の発見と開発プロセスを加速する 約束を約束しています